A multicenter experience of thrombotic microangiopathies in Turkey: The Turkish Hematology Research and Education Group (ThREG)-TMA01 study


Tekgunduz E., YILMAZ M., ERKURT M. A. , KİKİ İ., Kaya A. H. , KAYNAR L., ...Daha Fazla

TRANSFUSION AND APHERESIS SCIENCE, cilt.57, ss.27-30, 2018 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 57 Konu: 1
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1016/j.transci.2018.02.012
  • Dergi Adı: TRANSFUSION AND APHERESIS SCIENCE
  • Sayfa Sayıları: ss.27-30

Özet

Thrombotic microangiopathies (TMAs) are rare, but life-threatening disorders characterized by microangiopathic hemolytic anemia and thrombocytopenia (MAHAT) associated with multiorgan dysfunction as a result of microvascular thrombosis and tissue ischemia. The differentiation of the etiology is of utmost importance as the pathophysiological basis will dictate the choice of appropriate treatment.